We are live on ! Find out more
NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

47 hedge funds and large institutions have $9.59M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 15

29% less funds holding

Funds holding: 66 → 47 (-19)

37% less capital invested

Capital invested by funds: $15.3M → $9.59M (-$5.69M)

86% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 22

95% less call options, than puts

Call options by funds: $50K | Put options by funds: $1.06M

Holders
47
Holders Change
-19
Holders Change %
-28.79%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
14
Reduced
15
Closed
22
Calls
$50K
Puts
$1.06M
Net Calls
-$1.01M
Net Calls Change
-$651K

Top Buyers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
+$1.08M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$422K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$316K
4
Citadel Advisors
Citadel Advisors
Florida
+$117K
5
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$111K

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$4.46M
2
TI
Turner Investments
Pennsylvania
-$1.34M
3
AllianceBernstein
AllianceBernstein
Tennessee
-$1.01M
4
Northern Trust
Northern Trust
Illinois
-$481K
5
Millennium Management
Millennium Management
New York
-$236K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
51
Sabby Management
Florida
– -$226K -225 Closed
ARTA
52
A.R.T. Advisors
New York
– -$141K -141 Closed
TCIM
53
TIAA CREF Investment Management
New York
– -$136K -135 Closed
COPPSERS
54
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$118K -117 Closed
PP
55
Paloma Partners
Connecticut
– -$99K -99 Closed
VKH
56
Virtu KCG Holdings
New York
– -$90K -89 Closed
CS
57
Credit Suisse
Switzerland
– -$77K -76 Closed
CCA
58
Catalyst Capital Advisors
New York
– -$75K -75 Closed
AGM
59
Alpine Global Management
New York
– -$46K -45 Closed
AQR Capital Management
60
AQR Capital Management
Connecticut
– -$33K -33 Closed
DBG
61
De Burlo Group
Massachusetts
– -$32K -33 Closed
Squarepoint
62
Squarepoint
New York
– -$33K -33 Closed
LP
63
LMR Partners
United Kingdom
– -$30K -30 Closed
SFM
64
Soros Fund Management
New York
– -$30K -30 Closed
BRWA
65
B. Riley Wealth Advisors
Florida
– -$29K -28 Closed
PPA
66
Parametric Portfolio Associates
Washington
– -$27K -27 Closed
BJ
67
BlackRock Japan
Japan
– -$10K -10 Closed
TRCT
68
Tower Research Capital (TRC)
New York
– -$10K -10 Closed
LS
69
Lupo Securities
Illinois
– -$1.16K -1 Closed
1 2
3

NBSE Hedge Fund Activity: Q3 2015 in Review

47 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in NeuBase Therapeutics, Inc. Common Stock (NBSE) for Q3 2015, worth a combined $9.59M — down 37% from $15.3M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of NBSE and 3 opened new positions — a net loss of 19 holders — while 15 trimmed existing stakes and 14 added.

The largest buyer was BlackRock Institutional Trust, adding an estimated $1.08M. The largest seller was Broadfin Capital, exiting entirely with an estimated $4.46M sold.

  • 47 institutional investors held NeuBase Therapeutics, Inc. Common Stock (NBSE) as of Q3 2015, down from 66 in Q2 2015.
  • Funds reported $9.59M of NeuBase Therapeutics, Inc. Common Stock stock for Q3 2015, down 37% quarter-over-quarter.
  • 3 funds opened new NeuBase Therapeutics, Inc. Common Stock positions in Q3 2015 and 22 closed out, a net change of -19 holders.
  • The largest NeuBase Therapeutics, Inc. Common Stock buyer in Q3 2015 was BlackRock Institutional Trust, an estimated $1.08M added.
  • The largest NeuBase Therapeutics, Inc. Common Stock seller in Q3 2015 was Broadfin Capital, an estimated $4.46M sold.

Based on aggregated 13F filings for Q3 2015.